Published in Muscle Nerve on January 01, 2012
Specification of skeletal muscle differentiation by repressor element-1 silencing transcription factor (REST)-regulated Kv7.4 potassium channels. Mol Biol Cell (2012) 0.80
KCNQ and KCNE potassium channel subunit expression in bovine retinal pigment epithelium. Exp Eye Res (2013) 0.78
Membrane coordination of receptors and channels mediating the inhibition of neuronal ion currents by ADP. Purinergic Signal (2016) 0.75
Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension (2011) 5.73
Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs. J Hypertens (2012) 1.71
The identification and characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-dependent KCNQ potassium channels. J Biol Chem (2002) 1.65
[Prevalence of target organ damage and metabolic abnormalities in resistant hypertension]. Med Clin (Barc) (2011) 1.42
[Renal sympathetic denervation in refractory hypertension]. Med Clin (Barc) (2012) 1.41
New roles of myosin II during vesicle transport and fusion in chromaffin cells. J Biol Chem (2004) 1.34
Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J Biol Chem (2003) 1.31
Calmodulin regulates the trafficking of KCNQ2 potassium channels. FASEB J (2007) 1.26
Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J Biol Chem (2006) 1.20
Potassium channels: new targets in cancer therapy. Cancer Detect Prev (2006) 1.18
A novel KCNQ4 pore-region mutation (p.G296S) causes deafness by impairing cell-surface channel expression. Hum Genet (2007) 1.14
Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol (2004) 1.12
Three mechanisms underlie KCNQ2/3 heteromeric potassium M-channel potentiation. J Neurosci (2004) 1.12
Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages. Biochem Biophys Res Commun (2006) 1.08
Kv1.5 association modifies Kv1.3 traffic and membrane localization. J Biol Chem (2008) 1.03
Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis (2002) 1.01
The voltage-dependent K(+) channels Kv1.3 and Kv1.5 in human cancer. Front Physiol (2013) 1.00
Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels. Biochem Pharmacol (2010) 0.99
KCNE4 suppresses Kv1.3 currents by modulating trafficking, surface expression and channel gating. J Cell Sci (2009) 0.99
Presence of an established calcification marker in trabecular meshwork tissue of glaucoma donors. Invest Ophthalmol Vis Sci (2007) 0.99
KCNQ1/KCNE1 channels during germ-cell differentiation in the rat: expression associated with testis pathologies. J Cell Physiol (2005) 0.96
Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation. Biochim Biophys Acta (2008) 0.96
Potassium channels are a new target field in anticancer drug design. Recent Pat Anticancer Drug Discov (2007) 0.96
Calmodulin activation limits the rate of KCNQ2 K+ channel exit from the endoplasmic reticulum. J Biol Chem (2009) 0.95
Skeletal muscle Kv7 (KCNQ) channels in myoblast differentiation and proliferation. Biochem Biophys Res Commun (2008) 0.94
Pattern of Kv beta subunit expression in macrophages depends upon proliferation and the mode of activation. J Immunol (2005) 0.93
A pore residue of the KCNQ3 potassium M-channel subunit controls surface expression. J Neurosci (2010) 0.93
Modulation of aqueous humor outflow by ionic mechanisms involved in trabecular meshwork cell volume regulation. Invest Ophthalmol Vis Sci (2004) 0.92
Developmental switch of the expression of ion channels in human dendritic cells. J Immunol (2009) 0.91
Evidence for a calcification process in the trabecular meshwork. Exp Eye Res (2008) 0.91
Interferon-gamma regulates nucleoside transport systems in macrophages through signal transduction and activator of transduction factor 1 (STAT1)-dependent and -independent signalling pathways. Biochem J (2003) 0.90
Selective interaction of syntaxin 1A with KCNQ2: possible implications for specific modulation of presynaptic activity. PLoS One (2009) 0.89
Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences. J Gen Physiol (2010) 0.89
Expression of concentrative nucleoside transporters SLC28 (CNT1, CNT2, and CNT3) along the rat nephron: effect of diabetes. Kidney Int (2005) 0.89
Functional implications of KCNE subunit expression for the Kv7.5 (KCNQ5) channel. Cell Physiol Biochem (2009) 0.88
Kv7 channels can function without constitutive calmodulin tethering. PLoS One (2011) 0.88
Protein kinase C (PKC) activity regulates functional effects of Kvβ1.3 subunit on KV1.5 channels: identification of a cardiac Kv1.5 channelosome. J Biol Chem (2012) 0.86
Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface targeting. J Cell Physiol (2010) 0.86
The Kv7.2/Kv7.3 heterotetramer assembles with a random subunit arrangement. J Biol Chem (2012) 0.85
A non-canonical di-acidic signal at the C-terminus of Kv1.3 determines anterograde trafficking and surface expression. J Cell Sci (2013) 0.85
Emerging role for the voltage-dependent K+ channel Kv1.5 in B-lymphocyte physiology: expression associated with human lymphoma malignancy. J Leukoc Biol (2013) 0.85
Does laparoscopic sleeve gastrectomy have any influence on gastroesophageal reflux disease? Preliminary results. Surg Endosc (2014) 0.85
Differential expression of Kv1.3 and Kv1.5 voltage-dependent K+ channels in human skeletal muscle sarcomas. Cancer Invest (2012) 0.84
Multiple Kv1.5 targeting to membrane surface microdomains. J Cell Physiol (2008) 0.83
Ion channels and anti-cancer immunity. Philos Trans R Soc Lond B Biol Sci (2014) 0.82
Voltage-dependent K+ channel beta subunits in muscle: differential regulation during postnatal development and myogenesis. J Cell Physiol (2003) 0.82
Kv1.5 in the immune system: the good, the bad, or the ugly? Front Physiol (2010) 0.81
Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus. Cell Physiol Biochem (2010) 0.81
Differential regulation of Na(v)beta subunits during myogenesis. Biochem Biophys Res Commun (2008) 0.80
Circulating endothelial progenitor cells after kidney transplantation. Am J Transplant (2005) 0.80
Cooperativity between calmodulin-binding sites in Kv7.2 channels. J Cell Sci (2012) 0.79
The use of cork waste as a biosorbent for persistent organic pollutants-Study of adsorption/desorption of polycyclic aromatic hydrocarbons. J Environ Sci Health A Tox Hazard Subst Environ Eng (2011) 0.79
Hypertension confirmation and blood pressure control rates in epidemiological surveys. Eur J Cardiovasc Prev Rehabil (2008) 0.78
Abnormalities of vascular function in resistant hypertension. Blood Press (2011) 0.78
KCNE gene expression is dependent on the proliferation and mode of activation of leukocytes. Channels (Austin) (2013) 0.78
Surface expression and subunit specific control of steady protein levels by the Kv7.2 helix A-B linker. PLoS One (2012) 0.78
Voltage-dependent Na+ channel phenotype changes in myoblasts. Consequences for cardiac repair. Cardiovasc Res (2007) 0.78
Does a physiological role for KCNE subunits exist in the immune system? Commun Integr Biol (2010) 0.78
The systemic inflammatory response is involved in the regulation of K(+) channel expression in brain via TNF-alpha-dependent and -independent pathways. FEBS Lett (2004) 0.77
Impaired voltage-gated K+ channel expression in brain during experimental cancer cachexia. FEBS Lett (2003) 0.77
The neuronal serum- and glucocorticoid-regulated kinase 1.1 reduces neuronal excitability and protects against seizures through upregulation of the M-current. J Neurosci (2013) 0.77
The use of dansyl-calmodulin to study interactions with channels and other proteins. Methods Mol Biol (2013) 0.77
Cloning, molecular characterization and expression of ecto-nucleoside triphosphate diphosphohydrolase-1 from Torpedo electric organ. Neurochem Int (2006) 0.75
OS 28-01 BLOOD PRESSURE VARIABILITY IN PATIENTS TREATED WITH SPIRONOLACTONE OR RENAL DENERVATION.A RANDOMIZED CLINICAL TRIAL. J Hypertens (2016) 0.75
Concentrations of organochlorine pesticides and 2,4,6-trichloroanisole in cork bark. Chemosphere (2011) 0.75
Increased pulse pressure is associated with left atrial enlargement in resistant hypertensive patients. Blood Press (2013) 0.75
Clicked bis-PEG-peptide conjugates for studying calmodulin-Kv7.2 channel binding. Org Biomol Chem (2014) 0.75
Targeting potassium channels: new advances in cardiovascular therapy. Recent Pat Cardiovasc Drug Discov (2008) 0.75
Determination of free serotonin and its metabolite 5-HIAA in blood human samples with consideration to pre-analytical factors. Biomed Chromatogr (2014) 0.75
Reply. J Hypertens (2017) 0.75
Twenty-four-hour central blood pressure is not better associated with hypertensive target organ damage than 24-h peripheral blood pressure. J Hypertens (2017) 0.75
[Current role of angiotensin II receptor antagonists and their combination in the treatment of hypertension]. Med Clin (Barc) (2009) 0.75
[Prevalence of target organ damage and factors associated with cardiovascular events in subjects with refractory hypertension]. Med Clin (Barc) (2009) 0.75
BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients. J Nephrol (2003) 0.75
[Suggested conduct by the Argentine Circle of Digestive Motility for the management of gastroesophageal reflux disease]. Acta Gastroenterol Latinoam (2013) 0.75
OS 28-01 BLOOD PRESSURE VARIABILITY IN PATIENTS TREATED WITH SPIRONOLACTONE OR RENAL DENERVATION.A RANDOMIZED CLINICAL TRIAL. J Hypertens (2016) 0.75
Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease. Nefrologia (2014) 0.75